Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The British Society for Developmental Biology medal recognises outstanding achievements in the field.

Associate Professor Tatjana Sauka-Spengler is this year's winner of the Cheryll Tickle medal, which is awarded annually to the mid-career female scientist for outstanding achievements in the developmental biology research. 

Professor Sauka-Spengler has been a research group leader in the MRC Weatherall Institute of Molecular Medicine (WIMM) since 2012, and she has also previously won the prestigious Lister Institute Research Prize (2013) and the March of Dimes Basil O’Connor Research Award (2013).

Dr. Filipa Simões  from Professor Sauka-Spengler's group said: “Simply put, Tatjana is an outstanding supervisor and mentor, not only to the people directly working with her, but also to any other junior scientist that approaches her for guidance”. 

Professor Sauka-Spengler said: "I am absolutely delighted but also very humbled by this honour. I am grateful to all my fantastic students, postdocs, my collaborator and mentors and my institutions MRC WIMM, RDM and University of Oxford - I think I am extremely lucky to work with such a brilliant group of people."

Many congratulations to Professor Sauka-Spengler!

Read more on the British Society of Developmental Biology website. 

Similar stories

New Associate Professor appointments announced

Congratulations to Dr Bethan Psaila, Dr Benjamin Fairfax, Dr Hashem Koohy, Dr Andrew Blackford and Dr Oliver Bannard who have all been awarded the title of Associate Professor in recognition of their research achievements, contribution to teaching and contributions to the Medical Sciences Division.

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.